Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
BPC-157 structure

BPC-157

Healing & Recovery
Phase 1 Research
35%
Low-Moderate Risk
2/5

Dosing Protocol

Typical Dose 300 mcg
Range 200 - 500 mcg
Loading Phase 500 mcg × 14 days
Maintenance 250 mcg daily
Max Daily 750 mcg

Pharmacokinetics

Half-Life 15 min
Onset 3 min
Peak 10 min
Duration 2.0 hrs
Bioavailability 15%
Primary Route Subcutaneous

Administration

Routes Subcutaneous, Intramuscular, Oral
Injection Sites Abdomen, Thigh, Deltoid
Needle Gauge 29-31G
Syringe Type Insulin
Timing Fasted, Near Injury

Reconstitution

Diluent Bacteriostatic Water
Volume 2 mL
Concentration 2500 mcg/mL
Stability 30 days refrigerated
Vial Sizes 5, 10 mg

Special Instructions

Inject near injury site for localized effects. Can be taken orally for gut healing.